CIPLA
Back to Income Statement
|
CIPLA Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹6,291 Cr | ₹4,990 Cr | ₹4,512 Cr | ₹4,249 Cr | ₹3,181 Cr |
What is the latest Operating Profit of CIPLA ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹6,291 Cr |
| Mar2024 | ₹4,990 Cr |
| Mar2023 | ₹4,512 Cr |
| Mar2022 | ₹4,249 Cr |
| Mar2021 | ₹3,181 Cr |
How is Operating Profit of CIPLA Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹6,291 Cr | 26.07 | |
| Mar2024 | ₹4,990 Cr | 10.60 | |
| Mar2023 | ₹4,512 Cr | 6.20 | |
| Mar2022 | ₹4,249 Cr | 33.57 | |
| Mar2021 | ₹3,181 Cr | - | |
Compare Operating Profit of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹124,098.3 Cr | 1.4% | -1.4% | -1.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,171.0 Cr | 2.8% | 6.6% | -2.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,172.0 Cr | -0.2% | -0.7% | 10.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,176.0 Cr | -0.2% | 8.1% | 21.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,869.0 Cr | 2.7% | 1% | -3.4% | Stock Analytics | |
| MANKIND PHARMA | ₹92,658.1 Cr | 1.1% | -8.2% | -14.3% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.4% |
-1.4% |
-1.4% |
| SENSEX | 1.7% |
3.6% |
6.9% |
You may also like the below Video Courses